Recombinant polyvalent vaccine

Details for Australian Patent Application No. 2005338519 (hide)

Owner National Institute of Biomedical Innovation The Research Foundation for Microbial Diseases of Osaka University

Inventors Mori, Yasuko; Gomi, Yasuyuki; Yamanishi, Koichi; Somboonthum, Pranee; Yoshii, Hironori; Takahashi, Michiaki

Agent Freehills

Pub. Number AU-B-2005338519

PCT Pub. Number WO2007/060725

Filing date 24 November 2005

Wipo publication date 31 May 2007

Acceptance publication date 16 June 2011

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

A61K 39/25 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 31/22 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

Event Publications

12 June 2008 PCT application entered the National Phase

  PCT publication WO2007/060725 Priority application(s): WO2007/060725

16 June 2011 Application Accepted

  Published as AU-B-2005338519

13 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005338556-Novel loganin analogues and a process for the preparation thereof

2005338480-A method and arrangement for enabling multimedia communication